Minnesota Reaches Settlement with Eli Lilly to Cap Insulin Costs at $35

The agreement, which benefits up to 500,000 residents, follows a lawsuit alleging price gouging by the pharmaceutical giant.

Eli Lilly will donate insulin to 15 clinics across Minnesota and cap monthly insulin costs at $35 for the next five years.
The settlement is expected to benefit as many as 500,000 Minnesota residents, regardless of their insurance status.
Litigation against other insulin manufacturers, Sanofi-Aventis and Novo Nordisk, is still ongoing.
The agreement builds on previous efforts to make insulin more affordable, including federal price caps for Medicare patients.
The settlement comes amid a surge in diabetes rates in Minnesota, highlighting the urgency of affordable insulin access.